#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14648	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2069	702.9	0	.	n	.	0	C644T	SNP	644	644	C	898	898	T	843	T,C	445,354	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14648	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2069	702.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1704	1704	T	739	T,C	695,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14648	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2069	702.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1438	1438	C	826	C	787	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14648	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2069	702.9	0	HET	.	.	.	A69G	.	69	69	A	323	323	A	862	A,G	459,357	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26980	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3603	746.3	0	.	n	.	0	C1176T	SNP	1176	1176	C	1510	1510	T	886	T,C	841,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26980	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3603	746.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1671	1671	A	911	A,G	862,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26980	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3603	746.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2305	2305	C	800	C,G	759,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26980	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3603	746.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2379	2379	A	826	A	772	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26980	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3603	746.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2931	2931	C	807	C	756	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1902	folP	852	852	99.88	folP.l15.c4.ctg.1	1500	125.9	0	.	p	.	0	E151K	NONSYN	451	453	GAA	792	794	AAA	165;167;166	A,G;A;A	151,1;152;153	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1902	folP	852	852	99.88	folP.l15.c4.ctg.1	1500	125.9	1	SNP	p	R228S	1	.	.	682	684	AGC	1023	1025	AGC	190;191;193	A;G;C	184;184;183	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5084	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3427	147.8	0	.	p	.	0	K261del	DEL	781	781	A	1135	1135	A	150	A	144	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5084	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3427	147.8	1	SNP	p	S91F	0	.	.	271	273	TCC	625	627	TCC	183;181;180	T;C,T;C	175;171,1;171	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5084	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3427	147.8	1	SNP	p	D95G	0	.	.	283	285	GAC	637	639	GAC	186;183;183	G;A,C;C	176;171,1;173	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5084	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3427	147.8	1	SNP	p	D95N	0	.	.	283	285	GAC	637	639	GAC	186;183;183	G;A,C;C	176;171,1;173	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1618	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1388	116.0	1	SNP	p	G45D	0	.	.	133	135	GGC	508	510	GGC	185;184;186	G;G;C,T	167;170;170,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	844	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	964	86.8	0	.	n	.	0	A197.	DEL	197	197	A	525	525	A	199	A	189	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4914	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2944	166.3	1	SNP	p	D86N	0	.	.	256	258	GAC	570	572	GAC	196;196;196	G;A;C	187;187;188	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4914	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2944	166.3	1	SNP	p	S87W	0	.	.	259	261	AGT	573	575	AGT	195;195;194	A;G,C;T	188;185,1;182	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4914	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2944	166.3	1	SNP	p	S87I	0	.	.	259	261	AGT	573	575	AGT	195;195;194	A;G,C;T	188;185,1;182	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4914	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2944	166.3	1	SNP	p	S87R	0	.	.	259	261	AGT	573	575	AGT	195;195;194	A;G,C;T	188;185,1;182	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4914	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2944	166.3	1	SNP	p	S88P	0	.	.	262	264	TCC	576	578	TCC	196;198;195	T;C;C,G	184;184;182,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4220	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2610	161.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1584	1586	GGC	198;196;195	G;G;C	187;186;183	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3960	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2416	163.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1263	1265	GCA	210;212;216	G,A;C;A	198,1;202;207	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3960	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2416	163.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1266	1268	ATC	216;216;220	A;T;C	207;207;211	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3960	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2416	163.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1278	1280	GTG	209;208;210	G;T;G	204;201;205	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3960	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2416	163.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1278	1280	GTG	209;208;210	G;T;G	204;201;205	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3960	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2416	163.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1782	1784	ACC	213;212;211	A;C;C	190;189;191	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3960	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2416	163.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1836	1838	GCG	185;184;179	G;C;G	164;146;145	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3960	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2416	163.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1836	1838	GCG	185;184;179	G;C;G	164;146;145	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3960	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2416	163.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1959	1961	GGC	172;170;172	G,C;G;C	164,1;159;162	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3960	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2416	163.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1968	1970	GGC	176;176;177	G;GC,G;C	163;152,1;161	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3960	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2416	163.2	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1986	1988	CTG	166;170;170	C,G;T,C;G	124,5;127,1;133	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5892	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3145	186.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1684	1686	CCG	220;219;219	C;C;G	197;203;198	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2154	porA	1146	1146	99.65	porA.l15.c30.ctg.1	1938	110.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	566	566	C	146	C	132	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3098	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	216.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	340	342	GAA	247;244;242	G;A;A,T	231;232;226,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3098	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	216.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	628	630	GAT	247;247;250	G;A;T	226;226;228	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3098	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	216.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	751	753	TCA	272;271;274	T;C,G;A	260;254,1;262	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3098	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	216.7	0	.	p	.	0	D212N	NONSYN	634	636	GAT	862	864	AAT	246;249;246	A;A;T	238;239;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3098	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	216.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	880	882	GTC	229;229;231	G;T;C	223;220;226	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3098	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	216.7	0	.	p	.	0	F222S	NONSYN	664	666	TTT	892	894	TCT	250;252;255	T;C;T	236;238;241	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3098	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	216.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1210	1212	GCA	231;236;235	G;C;A	211;215;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3098	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	216.7	1	SNP	p	G120K	1	.	.	358	360	AAG	586	588	AAG	238;237;231	A;A;G	226;225;220	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3098	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	216.7	1	SNP	p	D121N	0	.	.	361	363	GAC	589	591	GAC	228;228;227	G;A;C	218;217;215	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3098	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	216.7	1	SNP	p	A121D	1	.	.	361	363	GAC	589	591	GAC	228;228;227	G;A;C	218;217;215	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11584	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4855	238.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1956	1958	AAT	258;257;259	A;A;T	245;242;243	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1218	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1024	118.0	1	SNP	p	V57M	1	.	.	169	171	ATG	445	447	ATG	228;226;228	A;T;G	220;218;219	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
